- Home
- MOLN vs ESGL Comparison
MOLN vs ESGL Comparison
Compare MOLN & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- ESGL
- Stock Information
- Founded
- MOLN 2004
- ESGL 1999
- Country
- MOLN Switzerland
- ESGL Singapore
- Employees
- MOLN N/A
- ESGL N/A
- Industry
- MOLN
- ESGL
- Sector
- MOLN
- ESGL
- Exchange
- MOLN Nasdaq
- ESGL Nasdaq
- Market Cap
- MOLN 142.6M
- ESGL 133.4M
- IPO Year
- MOLN 2021
- ESGL N/A
- Fundamental
- Price
- MOLN $3.53
- ESGL $2.80
- Analyst Decision
- MOLN
- ESGL
- Analyst Count
- MOLN 0
- ESGL 0
- Target Price
- MOLN N/A
- ESGL N/A
- AVG Volume (30 Days)
- MOLN 1.2K
- ESGL 45.7K
- Earning Date
- MOLN 08-25-2025
- ESGL 09-03-2025
- Dividend Yield
- MOLN N/A
- ESGL N/A
- EPS Growth
- MOLN N/A
- ESGL N/A
- EPS
- MOLN N/A
- ESGL N/A
- Revenue
- MOLN $2,525,030.00
- ESGL $6,099,784.00
- Revenue This Year
- MOLN N/A
- ESGL N/A
- Revenue Next Year
- MOLN $1,000.00
- ESGL N/A
- P/E Ratio
- MOLN N/A
- ESGL N/A
- Revenue Growth
- MOLN N/A
- ESGL N/A
- 52 Week Low
- MOLN $3.36
- ESGL $0.90
- 52 Week High
- MOLN $9.79
- ESGL $3.87
- Technical
- Relative Strength Index (RSI)
- MOLN 41.49
- ESGL 44.46
- Support Level
- MOLN $3.65
- ESGL $2.67
- Resistance Level
- MOLN $3.96
- ESGL $2.98
- Average True Range (ATR)
- MOLN 0.09
- ESGL 0.25
- MACD
- MOLN -0.01
- ESGL -0.04
- Stochastic Oscillator
- MOLN 20.33
- ESGL 27.67
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.